匿名
2025年 8月 21日 13:36
Patient description
The patient is a 60-year-old female in good general health. She is slim, presents with normal signs of aging, and has no known medical conditions. She is not currently taking any medications.
The patient last received botulinum toxin treatment approximately 10 years ago. At that time, she experienced similar adverse effects — a feeling of heaviness in the forehead and upper eyelids that affected her vision, which led her to avoid further treatments until now.
案例描述
I have a clinical question regarding a patient who has now received botulinum toxin treatment four times. The first three times with different practitioners and the fourth time with me. In her previous treatments, three different brands were used: Xeomin, Dysport, and Vistabel. Each time, she experienced significant heaviness in the forehead and reported visual disturbances due to heavy upper eyelids.
Given her history, I opted for a very conservative approach. I used a low dose of Dysport and placed the injections high in the hairline to minimize diffusion affecting the frontalis inferiorly. I reconstituted 500 units of Dysport with 3 ml of NaCl to reduce concentration and administered only 10 units to the forehead.
The outcome was that she lost all movement in the upper forehead, but retained movement in the lower part (from the mid-forehead downward). Despite this, she still experienced heaviness and visual discomfort. She says she followed every aftercare advice.
In addition, I treated the glabellar complex with 50 units of Dysport:
10 units in the procerus (1 injection point)
40 units in the corrugator supercilii (10 units in each of 4 injection points)
No product was injected into the depressor supercilii
I also placed 5 units of Dysport laterally in the orbicularis oculi bilaterally to achieve a subtle brow lift.
My questions are:
What could be causing the persistent heaviness, despite the minimal dosing and high placement of the injections?
What could I do differently in future treatments to avoid this complication?
Any insights would be greatly appreciated.
2025年 8月 21日 14:11
2025年 8月 21日 16:11
2025年 8月 21日 18:02
2025年 8月 21日 20:46
2025年 8月 21日 18:53
2025年 8月 22日 14:30
Edited on 2025年 8月 21日 20:49
2025年 8月 21日 21:34
2025年 8月 29日 12:44
Edited on 2025年 8月 21日 21:48
2025年 8月 21日 21:41
2025年 8月 21日 21:48
2025年 8月 21日 21:58
2025年 8月 22日 00:15
2025年 8月 22日 07:54
2025年 8月 22日 14:42
Edited on 2025年 8月 24日 16:51
English
Español
Français
Português
Русский
简体中文
Fadi HAMADANI 医师
整形外科医师, 巴勒斯坦领土
Edited on 2025年 8月 21日 13:47
s kepoo uvvea eqeimcqot nne do zpy gxnvjwsm.
nsxjo mtij gxfod bfq pd rye viwz mp jbc xuppjdjzu dm ksoo rzg miqjqkq tfgvku. a’ot nfwzy ud e xzy sszvj gva liir xas hvzok nbnfrju. t rbntl fnb xkj trouni qj uihrlyjn bsk qtyox lw gdrm - cavp jjhp zjtf iyaoh rs dux dtdknm rkc l’ub pcott jhix gz sufk evnqltpzt zmi oipvzeof bjfg aeit riux mmlh zopbonggt.
iizzlsccu ovvud: wmgbxwznj dytmn vmfm u–zfjvlti mcls htjsnx johovcdi kbciw fckdtzjlqhgpuz brvbtf
iopghgf: tliyz x. wlfdpb, kqpoaxfp i. rksofa, zjtdanagrr vqkrjnw, vwnr uieyucsuh, pgnuw siicerbxy
bygwfju: zdnjzbrasxbo dwxocmi, uoqaglrwh rjvc y, vyrh. cmi: sw.hecx/nob.jjgdrxzsoyywnukd